AquaPass Ltd
Yaacov Nitzan is a seasoned entrepreneur and engineer with extensive experience in the medical and biotechnology fields. Currently serving as Founder of AquaPass Ltd since January 2019 and Co-Founder of InnoHale Therapeutics since March 2020, Nitzan has a strong background in leadership roles, having previously founded and held executive positions at WhiteSwell and V-Wave. Nitzan also contributed as Director of R&D at Edwards Lifesciences and as a Project Manager at Biosense Webster. An alumnus of Technion - Israel Institute of Technology with a Bachelor of Science in Engineering and Tel Aviv University with a Master of Science in Biomedical/Medical Engineering, Nitzan possesses a solid educational foundation to complement a robust professional career.
This person is not in any teams
This person is not in any offices
AquaPass Ltd
AquaPass Ltd. is the developer and manufacturer of innovative solutions for the treatment of fluid overload in heart failure, renal failure, and lymphedema patients. The treatment is non-invasive and bypasses the renal system. It is intended to be used in the hospital or at home. Initial clinical trials confirmed the safety and performance of the system in chronic heart failure (CHF) patients and in end-stage renal disease (ESRD) patients.